Big 4 Diabetes articles

Access
BMJ - current paper copy in library, electronic access 3 months delay - NHS Athens
Lancet - electronic access 2 months delay - NHS Athens
JAMA - current electronic access - NHS Athens
NEJM - current paper copy in library, partial electronic access to recent articles - no password
full text electronic access - 3 months delay - NHS Athens

HEALTH AGENCIES UPDATE: Pesticides-Diabetes Link
JAMA current issue - 22 Jul 2008 21:34

EDITORIAL: Diabetes Mellitus--A Call for Papers
JAMA current issue - 22 Jul 2008 21:34

LETTERS: Oral Hypoglycemic Use and the SANDS Trial
JAMA current issue - 22 Jul 2008 21:34

COMMENTARY: Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities
JAMA current issue - 22 Jul 2008 21:34

LETTERS: Oral Hypoglycemic Use and the SANDS Trial--Reply
JAMA current issue - 22 Jul 2008 21:34

HEALTH AGENCIES UPDATE: Drugs and Cancer Risk
JAMA current issue - 22 Jul 2008 21:34

Statins for children?
...hypertension or diabetes, and those whose family history is unknown should also be screened.
The Lancet - 18 Jul 2008 10:44

BOOK REVIEW: Controversies in Treating Diabetes: Clinical and Research Aspects
Shortly before his election as president, John F. Kennedy wrote, "Let us welcome controversial books and controversial authors." To this statement we might add "and books on controversial medical topics," ...
New England Journal of Medicine - 16 Jul 2008 22:27

ORIGINAL CONTRIBUTION: Fetuin-A and Incident Diabetes Mellitus in Older Persons
...type 2 diabetes mellitus is unknown. Objective To determine whether fetuin-A levels are associated with incident diabetes in older persons. Design, Setting, and Participants Observational study among 3075 well-functioning persons aged 70 to 79 years. In this case-cohort study, we retrospectively measured fetuin-A levels in baseline serum among...
JAMA current issue - 8 Jul 2008 21:39

β-cell transplantation for diabetes therapy
In their Comment, Piero Ruggenenti and colleagues outline why they have decided not to continue islet-cell transplantation. We wish to clarify several points for readers.
The Lancet - 4 Jul 2008 10:48

β-cell transplantation for diabetes therapy – Authors' reply
In the largest series of islet transplant recipients treated with a common protocol of islet preparation and post-transplantation care (the Edmonton protocol), only 16 of 36 patients were still insulin-independent at 1 year; 10 had complete graft loss. Consistently, comparative studies have found that only 31% of islet recipients versus 96% of whol...
The Lancet - 4 Jul 2008 10:

β-cell transplantation for diabetes therapy
...treatment of diabetes.
The Lancet - 4 Jul 2008 10:48

β-cell transplantation for diabetes therapy
Piero Ruggenenti and colleagues (March 15, p 883) highlight their failure to establish a clinical islet transplantation programme. Results of islet transplantation are similar to those of the early days of organ transplantation, where initial success rarely met with long-term function. The Edmonton protocol achieved reproducible insulin independenc...
The Lancet - 4 Jul 2008 10:48

CORRECTIONS: Metformin versus Insulin for the Treatment of Gestational Diabetes
...of Gestational Diabetes . In the abstract (page 2003), under Results, the parenthetical information should read "(relative risk, 0.99; 95% confidence interval, 0.80 to ...
New England Journal of Medicine - 2 Jul 2008 22:20

Diabetes Vol 57, Part 7, 2008

We have full text access to this journal. Click here and login using NHS Athens

Protein kinase C function in muscle , liver , and beta - cells and its therapeutic implications for type 2 diabetes
Author(s):Schmitz - Peiffer , C . ; Biden , T . J .
ISSUE:2008 ; VOL 57 ; PART 7 (2008-July)
Page:1774-1783

Plasma C5 glucose - to - ^ 2H ~ 2O ratio does not provide an accurate assessment of gluconeogenesis during hyperinsulinemic - euglycemic clamps in either nondiabetic or diabetic humans
Author(s):Basu , R . ; Chandramouli , V . ; Dicke , B . ; Landau , B . R . ; Rizza , R . A
ISSUE:2008 ; VOL 57 ; PART 7 (2008-July)
Page:1800-1804

Blockade of alpha 4 integrin signaling ameliorates the metabolic consequences of high - fat diet - induced obesity
Author(s):Feral , C . C . ; Neels , J . G . ; Kummer , C . ; Slepak , M . ; Olefsky , J . M . ; Ginsberg , M . H .
ISSUE:2008 ; VOL 57 ; PART 7 (2008-July)
Page:1842-1851

Diabetes Care Vol 31, Part 7, 2008

We have full text access to this journal using NHS Athens. Click here to access.

Tumor necrosis factor - alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome
Author(s):Tesauro , M . ; Schinzari , F . ; Rovella , V . ; Melina , D . ; Mores , N . ; Barini , A . ; Mettimano , M . ; Lauro , D . ; Iantorno , M . ; Quon , M . J
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1439-1441

Meta - Analysis Rosiglitazone and risk of cancer : a meta - analysis of randomized clinical trials
Author(s):Monami , M . ; Lamanna , C . ; Marchionni , N . ; Mannucci , E .
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1455-1460

Perspectives on the News Approaches to treatment of pre - diabetes and obesity and promising new approaches to type 2 diabetes
Author(s):Bloomgarden , Z . T
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1461-1466

Editorial Death to carbohydrate counting ?
Author(s):Davis , N . J . ; Wylie - Rosett , J .
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1467-1468

NICE updates

The following guidance matching your health area preferences has been published or updated:

Diabetes - insulin pump therapy
Diabetes - insulin pump therapy
Diabetes in pregnancy

National Prescribing Centre's 'Week in Review' 4/7/08

NPCi Blog http://www.npci.org.uk/blog/
· MeReC Rapid Review: Is aliskiren plus losartan renoprotective in patients with type 2 diabetes and nephropathy? http://www.npci.org.uk/blog/?p=160

InfoPOEMs: http://www.essentialevidenceplus.com/
· Metformin effective for gestational diabetes http://www.essentialevidenceplus.com/infopoems/dailyInfoPOEM.cfm?view=121866

National electronic Library for Medicines (NeLM): http://www.nelm.nhs.uk
· FDA panel says diabetes drugs need cardiovascular risk studies http://www.nelm.nhs.uk/Record%20Viewing/vR.aspx?id=594929